基本信息
views: 176
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Désiré Collen holds a M.D. degree (1968) and Ph.D. degree in Chemistry (1974) from Katholieke Universiteit Leuven, Belgium. He served as Director of the Molecular Cardiovascular Medicine Group (comprising the Center for Molecular and Vascular Biology of the Katholieke Universiteit Leuven, and the Vesalius Research Center of the Flanders Institute for Biotechnology) in Leuven, Belgium until September 2008. He has research interests in translational research in biopharmaceutical drug development. His team initially developed t-PA, still the most effective drug for thrombolytic therapy of acute myocardial infarction. Dr. Collen has co-authored over 650 research papers and has received four honorary doctorates and several scientific awards including the Francqui Prize (Belgium), the Prix Louis Jeantet de Médecine (Switzerland), the Bristol-Myers-Squibb award for Cardiovascular Research (USA), and the Health Prize of the Interbrew-Baillet Latour Fund (Belgium) (jointly with P. Carmeliet). He was the Founder of and until August 2008 Chief Executive Officer of ThromboGenics, NV, a biopharmaceutical drug development company listed on Euronext Brussels. Till beginning of December 2013 he was the Chairman of the Board of ThromboGenics NV.
Research Interests
Papers共 144 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
mag(2014)
Cited24Views0Bibtex
24
0
H Roger Lijnen,Berthe Van Hoef,Florea Lupu,Lieve Moons, Peter Carmeliet,Arterioscler Thromb,Vasc Biol,Desire Collen
mag(2013)
Cited23Views0Bibtex
23
0
mag(2013)
Cited23Views0Bibtex
23
0
msra(2010)
Cited23Views0Bibtex
23
0
Désiré Collen,Hans Deckmyn, Thierry VandenDriessche,Simon F. De Meyer,Marinee K. Chuah,Inge Pareyn,Veerle Gillijns,Robert P
msra(2010)
Cited77Views0Bibtex
77
0
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn